PDX Pharmaceuticals, Inc.

Biotechnology company · Portland, Oregon, United States

PDX Pharmaceuticals, Inc. is a biotechnology company headquartered in Portland, Oregon, United States. It has received 12 US government small-business research awards (SBIR/STTR) from health agencies, $11 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $1.6 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

PDX Pharmaceuticals at a glance

Typebiotechnology company
HeadquartersPortland, Oregon, United States
Employees (self-reported, 2024)10
SEC CIK1795304

What does PDX Pharmaceuticals do?

US government research funding

12 SBIR/STTR small-business research awards from US health agencies, $10.7 million in total (2012 to 2024). NIH funding came from the National Cancer Institute, National Center for Advancing Translational Sciences.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1.6 million sold (2019).

Frequently asked questions about PDX Pharmaceuticals

Where is PDX Pharmaceuticals headquartered?

PDX Pharmaceuticals, Inc. is headquartered in Portland, Oregon, United States.

What does PDX Pharmaceuticals do?

PDX Pharmaceuticals, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences